Targeting LFA-1 synergizes with CD40/CD40L blockade for suppression of both CD4-dependent and CD8-dependent rejection

American Journal of Transplantation

Volumn 3, Issue 10, 2003, Pages 1251-1258

  Wang, Yue ^a   Gao, Donghong ^a   Lunsford, Keri E ^b   Frankel, Wendy L ^a   Bumgardner, Ginny L ^a,b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Costimulation; Rodent; T lymphocytes; Transgenic knockout; Transplantation

Indexed keywords

CD40 LIGAND; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; GRAFT REJECTION; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; LIVER CELL; MOUSE; NONHUMAN; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD40; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; CELL TRANSPLANTATION; FLOW CYTOMETRY; GRAFT REJECTION; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; T-LYMPHOCYTES; TIME FACTORS;

EID: 0141557857     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-6143.2003.00201.x     Document Type: Article

References (53)

1. Bumgardner GL, Heininger M, Li J et al. A functional model of hepatocyte transplantation for in vivo immunologic studies. Transplantation 1998; 65: 53-61.
2. Bumgardner GL, Li J, Heininger M, Ferguson RM, Orosz CG. In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model. Transplantation 1998; 65: 47-52.
3. + T-cell responses in acute rejection. Transplantation 1999; 68: 555-562.
4. Bumgardner GL, Gao D, Li J, Baskin J, Heininger M, Orosz CG. Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4 KO, and CD8 KO mice. Transplantation 2000; 70: 1771-1780.
5. + cells that independently initiate rejection of allogeneic hepatocytes in mice. Hepatology 2000; 32: 1018-1028.
6. + cells and CD40-CD40 ligand interactions. J Immunol 2001; 166: 3248-3255.
7. + T cells can trigger allograft rejection. J Immunol 2000; 165: 1111-1118.
8. + T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 1999; 104: 1715.
9. + T cells. J Immunol 1999; 163: 2358-2362.
10. He G, Hart J, Kim OS et al. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice. Transplantation 1999; 67: 131-137.
11. Guo Z, Meng L, Kim O et al. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway. Transplantation 2001; 71: 1351-1354.
12. + T lymphocytes in vivo. J Exp Med 2001; 194: 1339-1348.
13. Niimi M, Pearson TC, Larsen CP et al. The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo. J Immunol 1998; 161: 5331-5337.
14. Ozkaynak E, Gao W, Shemmeri N et al. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat Immunol 2001; 2: 591-596.
15. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J Exp Med 1997; 186: 47-55.
16. DeBenedette MA, Wen T, Bachmann MF et al. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J Immunol 1999; 163: 4833-4841.
17. Tan JT, Whitmire JK, Ahmed R, Pearson TC, Larsen CP. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J Immunol 1999; 163: 4859-4868.
18. Cannons J, Lau P, Ghumman B et al. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J Immunol 2001; 167: 1313-1324.
19. Wen T, Bukczynski J, Watts TH. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function. J Immunol 2002; 168: 4897-4906.
20. Takahashi C, Mittler RS, Vella AT. Differential clonal expansion of CD4 and CD8 T cells in response to 4-1BB ligation: contribution of 4-1BB during inflammatory responses. Immunol Lett 2001; 76: 183-191.
21. De Smedt T, Smith J, Baum P, Fanslow W, Butz E, Maliszewski C. Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo. J Immunol 2002; 168: 661-670.
22. + intraepithelial lymphocytes defined by OX40 (CD134) expression: effects on cell-mediated cytotoxicity, IFN-gamma, and IL-10 regulation. J Immunol 2001; 167: 6717-6723.
23. + T cell function in mice lacking the TNF superfamily member LIGHT. J Immunol 2002; 168: 4832-4835.
24. + T cell-mediated intestinal allograft rejection. J Immunol 2001; 167: 4796-4800.
25. + T cell responses by ICOS/B7h costimulation. J Immunol 2001; 167:132-139.
26. Kurzinger K, Reynolds T, Germain RN, Davignon D, Martz E, Springer TA. A novel lymphocyte function-associated antigen (LFA-1), cellular distribution, quantitative expression, and structure. J Immunol 1981; 127: 596-602.
27. Krensky AM, Sanchez-Madrid F, Robbins E, Nagy JA, Springer TA, Burakoff SJ. The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions. J Immunol 1983; 131: 611-616.
28. Martz E, Davignon D, Kurzinger K, Springer TA. The molecular basis for cytolytic T lymphocyte function: analysis with blocking monoclonal antibodies. Adv Exp Med Biol 1982; 146: 447-468.
29. Dustin ML, Shaw AS. Costimulation: building an immunological synapse. Science 1999; 283 (5402): 649-650.
30. + T cells become nonresponsive (anergic) following activation in the presence of costimulation. J Immunol 1999; 163: 102-110.
31. Ni HT, Deeths MJ, Li W, Mueller DL, Mescher MF. Signaling pathways activated by LFA-1 dependent costimulation. J Immunol 1999; 162: 5183-5189.
32. Binnerts ME, van Kooyk Y, Simmons DL, Figdor CG. Distinct binding of T lymphocytes to ICAM-1-2 or -3 upon activation of LFA-1. Eur J Immunol 1994; 24: 2155-2160.
33. Abraham C, Griffith J, Miller J. The dependence for leukocyte function-associated antigen-1/ICAM-1 interactions in T cell activation cannot be overcome by expression of high density TCR ligand. J Immunol 1999; 162: 4399-4405.
34. Salomon B, Bluestone JA. LFA-1 interaction with ICAM-1 and ICAM-2 regulates Th2 cytokine production J Immunol 1998; 161: 5138-5142.
35. + T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling. J Immunol 1999; 163: 4826-4832.
36. + T cells. Eur J Immunol 1999; 29: 809-814
37. + T cells are poorly costimulated by ICAM-1. Eur J Immunol 1999; 29: 45-53.
38. Nakakura EK, Shorthouse RA, Zheng B, McCabe SM, Jardieu PM, Morris RE. Long-term survival of solid organ allografts by brief anti-lymphocyte function-associated antigen-1 monoclonal antibody monotherapy. Transplantation 1996; 62: 547-552.
39. Isobe M, Suzuki J, Yamazaki S, Horie S, Okubo Y, Sekiguchi M. Assessment of tolerance induction to cardiac allograft by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies. J Heart Lung Transplant 1997; 16: 1149-1156.
40. Nicolls MR, Coulombe M, Yang H, Bolwerk A, Gill RG. Anti-LFA-1 therapy induces long-term islet allograft acceptance in the absence of IFN-gamma or IL-4. J Immunol 2000; 164: 3627-3634.
41. Malm H, Corbascio M, Osterholm C et al. 4-1BB induces long-term graft survival of allogeneic skin grafts and totally inhibits T-cell proliferation in LFA-1-deficient mice. Transplantation 2002; 73: 293-297.
42. Bumgardner GL, Li J, Apte S, Heininger M, Frankel WL. Effect of tumor necrosis factor à and intercellular adhesion molecule-1 expression on immunogenicity of murine liver cells in mice. Hepatology 1998; 28: 466-474.
43. Seglen PO. Preparation of rat liver parenchymal cells: enzymatic requirements for tissue dispersion. Exp Cell Res 1973; 82: 391-398.
44. Seglen PO. Preparation of isolated rat liver cells. Meth Cell Biol 1976; 13: 30-83.
45. Nicolls MR, Coulombe M, Beilke J, Gelhaus HC, Gill RG. CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways. J Immunol 2002; 169: 4831-4839.
46. Andrew DP, Spellberg JP, Takimoto H, Schmits R, Mak TW, Zukowski MM. Transendothelial migration and trafficking of Leukocytes in LFA-1-deficient mice. Eur J Immunol 1998; 28: 1959-1969.
47. Norris S, Collins C, Doherty DG et al. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. Hepatology 1998; 28: 84-90.
48. + T cell immune response against Encephalitozoon cuniculi infection. J Immunol 2001; 166: 7389-7397.
49. Schramm R, Schaefer T, Menger MD, Thorlacius H. Acute mast cell-dependent neutrophil recruitment in the skin is mediated by KC and LFA-1: inhibitory mechanisms of dexamethasone. J Leukoc Biol 2002; 72: 1122-1132.
50. Henderson RB, Lim LH, Tessier PA et al. The use of lymphocyte function-associated antigen (LFA)-1-deficient mice to determine the role of LFA-1, Mac-1, and alpha4 integrin in the inflammatory response of neutrophils. J Exp Med 2001; 194: 219-226.
51. Ding ZM, Babensee JE, Simon SI et al. Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J Immunol 1999; 163: 5029-5038.
52. Morita K, Miura M, Paolone DR et al. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection. J Immunol 2001; 167: 2979-2984.
53. + T cells. Proc Natl Acad Sci USA 2001; 98: 241-246.